Hyperbaric Oxygen Therapy Market - Global Size by 2030
[Research Report] The hyperbaric oxygen therapy market is projected to surge from US$ 402.49 million in 2022 to US$ 522.37 million by 2030; the market is estimated to grow at a CAGR of 3.3% during 2022–2030.
Analyst Perspective:
Hyperbaric oxygen therapy (HBOT) is conventionally used to treat people suffering from medical conditions associated with rapid changes in atmospheric pressure around them. Increased blood oxygen levels support vascular development, essential for healing in people with diabetes. The enhanced oxygen levels in the body can improve the healing of certain wounds and promote repair of damaged tissue. It is commonly used for conditions such as non-healing wounds, diabetic foot ulcers, decompression sickness (commonly seen in recreational divers), carbon monoxide poisoning, and certain types of infections, eventually leading to the growth of the hyperbaric oxygen therapy market
The increasing incidences of acute and chronic wounds, and the rising popularity of leisure and adventure activities are driving the hyperbaric oxygen therapy market. According to the Outdoor Participation Trends Report, in 2020, 53% of Americans of age 6 and above engaged in at least one form of outdoor recreational activity, representing the highest participation rate on record. Further, a surging number of pediatric open heart surgery cases is expected to create opportunities for the market in the future. However, the high cost associated, poor reimbursement policies, and side effects hinders the growth of the hyperbaric oxygen therapy market.
Market Overview:
HBOT is a medical treatment involving breathing pure oxygen in a pressurized environment. The treatment is usually provided in a special room or chamber. The pressure in the chamber is increased to a level above atmospheric pressure, allowing the lungs to absorb more oxygen than would be possible by breathing in pure oxygen at normal atmospheric pressure.
A special tub-like chamber, in which HBOT is given, is made of (mostly) transparent material to prevent claustrophobia episodes among patients. A controlled supply of 100% pure oxygen, which is higher than normally inhaled levels, results in the dissolution of elevated oxygen levels in several body fluids, such as blood and cerebrospinal fluid. Single and multiuser chambers are commercially available for these therapies; a multiuser chamber is designed to accommodate up to 6 patients at a time. Several advantages of HBOT include reduced inflammation, hyperoxygenation, and antimicrobial effects. Moreover, it promotes the growth of several new blood vessels in the body.
HBOT is gaining popularity in healthcare settings owing to the increasing incidence of wound infections, gas embolism, and carbon monoxide poisoning. Furthermore, increasing government spending on the development of medical facilities, rising cases of osteomyelitis in the geriatric population, growing awareness about anemia, and healthcare spending habits among consumers are expected to provide an impetus for the growth of the hyperbaric oxygen therapy market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Hyperbaric Oxygen Therapy Market: Strategic Insights
Market Size Value in US$ 402.49 million in 2022 Market Size Value by US$ 522.37 million by 2030 Growth rate CAGR of 3.3% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Hyperbaric Oxygen Therapy Market: Strategic Insights
| Market Size Value in | US$ 402.49 million in 2022 |
| Market Size Value by | US$ 522.37 million by 2030 |
| Growth rate | CAGR of 3.3% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Driver:
Rising Burden of Acute and Chronic Wounds Drives Global Hyperbaric Oxygen Therapy Market
According to the report released by the American Burn Association in February 2021, approximately 400,000 people are treated for burns annually in the US. HBOT supports wound healing by delivering oxygen-rich plasma to oxygen-depleted tissue. The therapy reduces swelling by supplying oxygen to tissues, helping to break the cycle of swelling, oxygen deprivation, and tissue death. North Carolina military veterans who were suffering from post-traumatic stress disorder and traumatic brain injuries are also getting relief through HBOT. The therapy, performed at the Extivita Clinic in Durham, uses 100% oxygen in two General Assembly-funded hypobaric chambers.
As per a study published by the National Library of Medicine, in February 2021, diabetes causes severe and diffuse disease below the knee. The chances of developing a lifetime risk of diabetic foot ulcer range from 19.0% to 34.0%. As per the study published in May 2021 by Systemic Reviews, ~60.0% of venous leg ulcers in patients result in chronic wounds. A study published by Biomedicines in November 2021 states that the prevalence of venous leg ulcers is 1.5–3.0% in the general population. Therefore, increasing cases of acute and chronic wounds boost the demand for hyperbaric oxygen therapy devices.
Segmental Analysis:
Based on product, the hyperbaric oxygen therapy market is segmented into hyperbaric oxygen chambers, and accessories and consumables. The hyperbaric oxygen chambers segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR of 3.5% during 2022–2030.
The hyperbaric oxygen therapy market, based on capacity, is segmented into monoplace and multiplace. The monoplace segment held a larger market share in 2022. The multiplace segment is anticipated to register a higher CAGR of 3.4% from 2022 to 2030. Monoplace hyperbaric chambers are small chambers used for hyperbaric oxygen delivery to a single patient. These are chambers that the patient usually enters while lying down. These devices are typically used on one person at a time, usually in a lying position. Additionally, they only allow certain intravenous lines and ventilation ducts to penetrate the torso. Due to their easy installation and handling and low maintenance costs, monoplace systems have higher commercial availability.
Multiplace systems are expensive and also require more people for maintenance and operation. These devices are suitable for many patients with different medical conditions and make it easier for medical staff to monitor the signs and symptoms of each patient. The key unique selling point (USP) of multiplace chambers is that they enable longer treatment times for the patient. Increasing awareness among hospital professionals about the benefits of this system is expected to boost the segment. Commonly used and commercially available multiplace systems include the OxyHeal 5000 rectangular multiplace hyperbaric chamber, the OxyHeal 4000 multiplace hyperbaric chamber, and the decompression hyperbaric chamber. Therefore, the growing need to treat patients in one cycle has increased the demand for such systems in hospitals.
Based on application, the hyperbaric oxygen therapy market is segmented into decompression sickness, wound healing, infectious diseases, and others. The wound healing segment held the largest market share in 2022. The market for the same segment is anticipated to grow at the fastest CAGR of 3.7% during 2022–2030.
NCBI estimates that approximately 1–2% of the population from developed countries experience a chronic wound during their lifetime. The proportion is likely to be higher in emerging markets. In addition, the increasing popularity of adventure activities and recreational sports among a large part of the world's population is also responsible for the increasing wound cases.
Wound healing usually involves healing the skin. It begins immediately after an injury to the epidermal layer and can last for years. This dynamic process involves highly organized cellular, humoral, and molecular mechanisms. It consists of three overlapping phases: inflammation, proliferation, and remodeling. Commercially accessible products such as BARA-MEDXD, BARA-MED, BARA-PRESS Software Control System, BARA-MED Select, and PAH-S1 hyperbaric chambers are mainly used for treating wounds and decompression sickness. Such a large product portfolio for wound treatment is also one of the few factors responsible for the segment's growth.
Based on the end user, the hyperbaric oxygen therapy market is segmented into hospitals and specialty centers, ambulatory surgical centers, and others. The hospitals and specialty centers segment held the largest market share in 2022. It is anticipated to register the highest CAGR of 3.5% during 2022–2030.
Regional Analysis:
North America dominates the hyperbaric oxygen therapy market. The North America hyperbaric oxygen therapy market was valued at US$ 197.66 million in 2022 and is projected to reach US$ 251.39 million by 2030; it is expected to register a CAGR of 3.1% during 2022–2030. The North America hyperbaric oxygen therapy market is segmented into the US, Canada, and Mexico. Market growth in this region is due to the increase in chronic wound cases due to the growing incidence of chronic diseases and the growing geriatric population. According to the report released in September 2022 by the Trust for America's Health Organization, ~22 states in the US had adult obesity rates above 35% in 2021. Obesity is a major cause of chronic wound development as it leads to vascular insufficiency. Vascular insufficiency leads to poor oxygen supply, leading to delays in normal wound healing and even tissue necrosis. Major product launches, high concentration of market players or manufacturers, acquisitions, and partnerships between key players, and increasing use of hyperbaric oxygen therapy devices in the US are a few key factors boosting the growth of the market in North America. In July 2021, the US Food and Drug Administration (FDA) approved the use of hyperbaric oxygen therapy (HBOT/HBO2) to treat various medical conditions, such as carbon monoxide poisoning, radiation injury, burns, anemia, and others. Therefore, such cases are expected to increase the demand for HBOT devices and drive market growth in the US. These factors are responsible for expanding and strengthening the hyperbaric oxygen therapy market in the region.
Asia Pacific is anticipated to be the fastest-growing region in the hyperbaric oxygen therapy market during the forecast period. Emerging countries such as India, China, the Philippines, Vietnam, and Brazil record strong economic growth. The growing population and increasing need for wound healing treatments fuel the demand for HBOT in this region. Growing disposable income has led to consumers seeking technologically advanced medical treatments and therapies. APAC is expected to achieve tremendous growth in the market owing to the proliferating medical tourism industry, increasing per capita income, and rising public awareness of the benefits of HBOT in the coming years.
Key Player Analysis:
Perry Baromedical; Sechrist Industries, Inc.; Tekna Hyperbaric; Pan America Hyperbarics, Inc.; HAUX-LIFE-SUPPORT GmbH; PCCI, Inc.; Hipertech Inc.; SOS Group GBR Ltd; HEARMEC; OxyHealth; Airox Technologies Limited; and Biovision Healthcare are among the key players analyzed during the hyperbaric oxygen therapy market study.
Hyperbaric Oxygen Therapy Market Report Scope
Recent Developments:
Companies operating in the hyperbaric oxygen therapy market adopt such as mergers and acquisitions. A few of the recent market developments are listed below:
- In May 2021, CūtisCare, a leading multi-site provider of hyperbaric services to trauma centers and acute care hospitals, broadcasted the official launch of the hyperbaric website and nationwide campaign. The company aims to raise awareness about hyperbaric oxygen therapy to treat various chronic diseases effectively.
- In January 2022, Narayana Health City announced the opening of a dedicated hyperbaric oxygen plant with regenerative medicine. The facility will provide HBOT to treat infections and age-related medical conditions.
- In January 2023, Kamalaya Koh Samui, Thailand, introduced new integrative treatments at its Longevity House. A range of new treatments was introduced to support integrative healing, including intravenous vitamin infusions, hyperbaric oxygen therapy, ozone therapy, and high-sensitivity cancer screenings.
- In February 2023, Maui Health opened a new outpatient facility in Hawaii that adopts a comprehensive approach to treat patients suffering from non-healing wounds, which includes hyperbaric oxygen therapy.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Capacity, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The hyperbaric oxygen therapy market majorly consists of the players such as Perry Baromedical; Sechrist Industries, Inc.; Tekna Hyperbaric; Pan America Hyperbarics, Inc.; HAUX-LIFE-SUPPORT GmbH; PCCI, Inc.; Hipertech Inc.; SOS Group GBR Ltd; HEARMEC; OxyHealth; Airox Technologies Limited; and Biovision Healthcare.
The hyperbaric oxygen therapy market was valued at US$ 402.49 million in 2022.
The hyperbaric oxygen therapy market is expected to be valued at US$ 522.37 million in 2030.
Hyperbaric oxygen therapy (HBOT) is performed in a special tub-like chamber made of (mostly) transparent material to lower the probability of claustrophobia episodes among patients. The chambers have a controlled supply of 100% pure oxygen, which is much higher than normally inhaled is present in these chambers. As a result, inhaled oxygen is dissolved in several body fluids, such as blood and cerebrospinal fluid. Single and multiuser chambers are commercially available for these therapies; a multiuser chamber is designed to accommodate up to 6 patients at a time. Several advantages of HBOT include reduced inflammation, hyperoxygenation, and antimicrobial effects, and it also promotes the growth of several new blood vessels in the body.
The factors driving the growth of the hyperbaric oxygen therapy market include the surging burden of acute and chronic wounds and the introduction of technologically advanced systems.
The global hyperbaric oxygen therapy market, based on product is segmented into hyperbaric oxygen chambers, and accessories and consumables. The hyperbaric oxygen chambers segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR of 3.5% during 2022–2030. Based on capacity, is segmented into monoplace and multiplace. The monoplace segment held a larger market share in 2022. The multiplace segment is anticipated to register a higher CAGR of 3.4% from 2022 to 2030. Based on application, the hyperbaric oxygen therapy market is segmented into decompression sickness, wound healing, infectious diseases, and others. The wound healing segment held the largest market share in 2022. It is expected to record the highest CAGR of 3.7% during 2022–2030. In terms of end user, the hyperbaric oxygen therapy market is segmented into hospitals and specialty centers, ambulatory surgical centers, and others. The hospitals and specialty centers segment held the largest market share in 2022. The same is said to register the highest CAGR of 3.5% during 2022–2030.
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Hyperbaric Oxygen Therapy Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Hyperbaric Oxygen Therapy Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Hyperbaric Oxygen Therapy Market - Global Market Analysis
6.1 Hyperbaric Oxygen Therapy - Global Market Overview
6.2 Hyperbaric Oxygen Therapy - Global Market and Forecast to 2030
7. Hyperbaric Oxygen Therapy Market – Revenue Analysis (USD Million) – By Product, 2020-2030
7.1 Overview
7.2 Hyperbaric Oxygen Chambers
7.3 Accessories and Consumables
8. Hyperbaric Oxygen Therapy Market – Revenue Analysis (USD Million) – By Capacity, 2020-2030
8.1 Overview
8.2 Monoplace
8.3 Multiplace
9. Hyperbaric Oxygen Therapy Market – Revenue Analysis (USD Million) – By Application, 2020-2030
9.1 Overview
9.2 Decompression Sickness
9.3 Wound Healing
9.4 Infectious Diseases
9.5 Others
10. Hyperbaric Oxygen Therapy Market – Revenue Analysis (USD Million) – By End User, 2020-2030
10.1 Overview
10.2 Hospitals and Specialty Centers
10.3 Ambulatory Surgical Centers
10.4 Others
11. Hyperbaric Oxygen Therapy Market - Revenue Analysis (USD Million), 2020-2030 – Geographical Analysis
11.1 North America
11.1.1 North America Hyperbaric Oxygen Therapy Market Overview
11.1.2 North America Hyperbaric Oxygen Therapy Market Revenue and Forecasts to 2030
11.1.3 North America Hyperbaric Oxygen Therapy Market Revenue and Forecasts and Analysis - By Product
11.1.4 North America Hyperbaric Oxygen Therapy Market Revenue and Forecasts and Analysis - By Capacity
11.1.5 North America Hyperbaric Oxygen Therapy Market Revenue and Forecasts and Analysis - By Application
11.1.6 North America Hyperbaric Oxygen Therapy Market Revenue and Forecasts and Analysis - By End User
11.1.7 North America Hyperbaric Oxygen Therapy Market Revenue and Forecasts and Analysis - By Countries
11.1.7.1 United States Hyperbaric Oxygen Therapy Market
11.1.7.1.1 United States Hyperbaric Oxygen Therapy Market, by Product
11.1.7.1.2 United States Hyperbaric Oxygen Therapy Market, by Capacity
11.1.7.1.3 United States Hyperbaric Oxygen Therapy Market, by Application
11.1.7.1.4 United States Hyperbaric Oxygen Therapy Market, by End User
11.1.7.2 Canada Hyperbaric Oxygen Therapy Market
11.1.7.2.1 Canada Hyperbaric Oxygen Therapy Market, by Product
11.1.7.2.2 Canada Hyperbaric Oxygen Therapy Market, by Capacity
11.1.7.2.3 Canada Hyperbaric Oxygen Therapy Market, by Application
11.1.7.2.4 Canada Hyperbaric Oxygen Therapy Market, by End User
11.1.7.3 Mexico Hyperbaric Oxygen Therapy Market
11.1.7.3.1 Mexico Hyperbaric Oxygen Therapy Market, by Product
11.1.7.3.2 Mexico Hyperbaric Oxygen Therapy Market, by Capacity
11.1.7.3.3 Mexico Hyperbaric Oxygen Therapy Market, by Application
11.1.7.3.4 Mexico Hyperbaric Oxygen Therapy Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Rest of Europe
11.3 Asia-Pacific
11.3.1 Australia
11.3.2 China
11.3.3 India
11.3.4 Japan
11.3.5 South Korea
11.3.6 Rest of Asia-Pacific
11.4 Middle East and Africa
11.4.1 South Africa
11.4.2 Saudi Arabia
11.4.3 U.A.E
11.4.4 Rest of Middle East and Africa
11.5 South and Central America
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Rest of South and Central America
12. Industry Landscape
12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments
13. Competitive Landscape
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration
14. Hyperbaric Oxygen Therapy Market - Key Company Profiles
14.1 Perry Biomedical
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
Note - Similar information would be provided for below list of companies
14.2 Sechrist Industries, Inc.
14.3 Tekna Hyperbaric
14.4 Pan America Hyperbarics, Inc.
14.5 HAUX-LIFE-SUPPORT GmbH
14.6 PCCI Inc.
14.7 Hipertech Inc.
14.8 SOS Group GBR Ltd.
14.9 HEARMEC
14.10 OxyHealth
14.11 Airox Technologies Limited
14.12 Biovision Healthcare
15. Appendix
15.1 Glossary
15.2 About The Insight Partners
15.3 Market Intelligence Cloud
The List of Companies - Hyperbaric Oxygen Therapy Market
- Perry Baromedical
- Sechrist Industries, Inc.
- Tekna Hyperbaric
- Pan America Hyperbarics, Inc.
- HAUX-LIFE-SUPPORT GmbH
- PCCI, Inc.
- Hipertech Inc.
- SOS Group GBR Ltd
- HEARMEC
- OxyHealth
- Airox Technologies Limited
- Biovision Healthcare
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For